World's Best Scientists 2026 revealed!
Kenneth F. Bradstock

Kenneth F. Bradstock

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
17835
World Ranking
5971
National Ranking
143

Medicine

D-Index
73
Citations
17906
World Ranking
19678
National Ranking
668

Kenneth F. Bradstock publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Kenneth F. Bradstock sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 360 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Kenneth F. Bradstock D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth F. Bradstock sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 73 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Kenneth F. Bradstock is affiliated with Westmead Hospital in Australia and has contributed to research primarily in the field of Medicine, with a strong focus on hematological and pediatric conditions. Their scholarly output spans across several subfields, including Public Health, Environmental and Occupational Health, Hematology, Genetics, Pediatrics, Perinatology and Child Health, and Pathology and Forensic Medicine.

Their research topics highlight a focus on blood-related disorders and cancers. Key areas include:

  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Childhood Cancer Survivors' Quality of Life
  • Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Blood disorders and treatments
  • Adolescent and Pediatric Healthcare

Kenneth F. Bradstock has published extensively in these areas, producing papers in venues such as Blood Advances, the Journal of Molecular Diagnostics, Leukemia & lymphoma/Leukemia and lymphoma, and Blood Neoplasia. Notable recent papers include:

  • RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML, 2020, Blood Advances
  • An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as in children with ALL, 2021, Blood Advances
  • Sensitive Measurement of Minimal Residual Disease in Blood by HAT-PCR, 2022, Journal of Molecular Diagnostics
  • Successful treatment of acute lymphoblastic leukemia (ALL) during pregnancy using a pediatric-based protocol incorporating pegylated asparaginase, 2023, Leukemia & lymphoma/Leukemia and lymphoma
  • Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol, 2024, Blood Neoplasia

Throughout their research career, Bradstock has collaborated frequently with other researchers, including Matthew Greenwood, Luciano Dalla-Pozza, Sally Mapp, Toby N. Trahair, and Rosemary Sutton. These collaborations have resulted in multiple coauthored works, especially within the subject of pediatric and hematological diseases.

The publication venues most commonly associated with their work are:

  • Blood Advances
  • Journal of Molecular Diagnostics
  • Leukemia & lymphoma/Leukemia and lymphoma
  • Blood Neoplasia

Best Publications

  • A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

    JF Bishop;JP Matthews;Ga Young;J Szer

  • OUTCOME OF TREATMENT IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: ANALYSIS OF THE LALA-94 TRIAL

    Xavier Thomas;Jean Michel Boiron;Françoise Huguet;Hervé Dombret

  • Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

    Andrew Spencer;H. Miles Prince;Andrew W. Roberts;Ian W. Prosser

  • Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

    Kirit M Ardeshna;Wendi Qian;Paul Smith;Nivette Braganca

  • G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.

    Linda J. Bendall;Kenneth F. Bradstock

  • All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

    Harry J. Iland;Harry J. Iland;Ken Bradstock;Ken Bradstock;Shane G. Supple;Alberto Catalano

  • Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia.

    George Janossy;Fred J. Bollum;Kenneth F. Bradstock;Andrew McMichael

  • Filgrastim in Patients with Chemotherapy-Induced Febrile Neutropenia: A Double-Blind, Placebo-Controlled Trial

    Darryl W. Maher;Graham J. Lieschke;Michael Green;James Bishop

  • Real-time quantitative PCR analysis can be used as a primary screen to identify patients with CML treated with imatinib who have BCR-ABL kinase domain mutations.

    Susan Branford;Zbigniew Rudzki;Ian Parkinson;Andrew Grigg

  • Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.

    Norbert Schmitz;Meral Beksac;Dirk Hasenclever;Andrea Bacigalupo

  • Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.

    H.G. Prentice;G. Janossy;D. Skeggs;H.A. Blacklock

  • Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

    Orla Morrissey;Orla Morrissey;Sharon C-A Chen;Sharon C-A Chen;Sharon C-A Chen;Tania Christine Sorrell;Tania Christine Sorrell;Tania Christine Sorrell;Sam Milliken

  • Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro

    J Juarez;K F Bradstock;D J Gottlieb;L J Bendall

  • The human thymic microenvironment: an immunohistologic study.

    G. Janossy;J. A. Thomas;F. J. Bollum;S. Granger

  • Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial

    E. Tavernier;J. M. Boiron;F. Huguet;K. Bradstock

  • Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.

    B George;N Pati;N Gilroy;M Ratnamohan

  • Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials.

    Gary Brooke;Tony Rossetti;Rebecca Pelekanos;Nina Ilic

  • Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.

    Naveed I. Khan;Kenneth F. Bradstock;Linda J. Bendall

  • Terminal Transferase Enzyme Assay and Immunological Membrane Markers in the Diagnosis of Leukaemia: a Multiparameter Analysis of 300 Cases

    G. Janossy;A. V. Hoffbrand;M. F. Greaves;K. Ganeshaguru

  • Use of anti t cell mono clonal antibody okt 3 to prevent acute graft vs. host disease in allogeneic bone marrow transplantation for acute leukemia

    H. G. Prentice;H. A. Blacklock;G. Janossy;K. F. Bradstock

Frequent Co-Authors

Jeff Szer
Jeff Szer Peter MacCallum Cancer Centre
Derek N.J. Hart
Derek N.J. Hart University of Sydney
Andrew Grigg
Andrew Grigg Austin Hospital
John F. Seymour
John F. Seymour Peter MacCallum Cancer Centre
Emmanuel J. Favaloro
Emmanuel J. Favaloro Westmead Hospital
Andrew W. Roberts
Andrew W. Roberts Walter and Eliza Hall Institute of Medical Research
George Janossy
George Janossy University of the Witwatersrand
Ian Kerridge
Ian Kerridge University of Sydney
John V. Reynolds
John V. Reynolds Trinity College Dublin
A. V. Hoffbrand
A. V. Hoffbrand The Royal Free Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry often opens doors to a variety of rewarding careers in healthcare and research. For students considering versatile and flexible study options, online degree and certificate programs are becoming increasingly popular—and accessible. Many choose to fast-track their professional growth with the shortest online pmhnp certificate programs, which prepare graduates for specialized roles in psychiatric and mental health nursing. Others with a master’s education might pursue a post masters np program to step into family nurse practitioner positions.

Nutrition is another growing field for biology graduates. Flexible, accredited online paths, such as a dietitian degree online, can help future nutritionists or dietitians become certified faster and at a lower cost. Similarly, those looking to advance in nursing can benefit from the easiest rn to bsn program for a smoother transition into advanced clinical or leadership roles. Whether you are seeking speed, affordability, or career advancement, these online programs offer tailored solutions for those with a background in biology and biochemistry.

Best Scientists Citing Kenneth F. Bradstock

Trending Scientists

Recently Published Articles